Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Singapore Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20064
20073
20082
20101
20111
20122
20133
20142
20151
20161
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting2
Recruiting2
No longer available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Bristol-Myers Squibb5
Pfizer5
Ariad Pharmaceuticals2
Singapore General Hospital2
Teva Branded Pharmaceutical Products R&D, Inc.2
Ascentage Pharma Group Inc.1
Gamida Cell ltd1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive30
Leukemia6
Bone Marrow Diseases4
Leukemia, Myeloid4
Myeloproliferative Disorders4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Diseases3
Neoplasms by Histologic Type3
Blast Crisis2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.